Streetbeat News

Products Services

MNPR

Monopar Therapeutics reported that both patients treated in the Phase 1B study at the 650 mg/m2 dose experienced tumor size reductions of 18% and 20% respectively after the first two cycles of Camsirubicin treatment. The patients are set to receive additional cycles of treatment, which may result in further tumor size reduction.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:20 am

PRAX

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) announced further data from two additional analyses of the Essential1 study for ulixacaltamide. The results showed maintained or improved efficacy in patients dosed up to 14 weeks. Ulixacaltamide is a small molecule inhibitor of T-type calcium channels being developed for Essential Tremor.

Portfolio Pulse from Charles Gross

August 08, 2023 | 11:16 am

AAPL

Apple Inc. (NASDAQ:AAPL) is expected to switch to the USB Type-C port from the Lightning connector with the iPhone 15 series, according to leaked images and reports. The change is in response to new European Union regulations. The iPhone 15 series is expected to launch on September 13. Other updates include stacked battery technology, a periscope camera on the top-tier iPhone 15 Pro Max, a programmable action button on the ‘Pro' models, and a price hike for the ‘Pro' models. Apple could also increase the baseline storage to 256GB from 128GB.

Portfolio Pulse from Rounak Jain

August 08, 2023 | 11:12 am

NVO

Novo Nordisk announced positive results from the SELECT cardiovascular outcomes trial, showing that Semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20%. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:51 am

SPIR

Spire Global has secured a contract from GHGSat to expand its satellite constellation for emissions monitoring. The contract involves building, launching, and operating four additional 16U satellites carrying GHGSat payloads. The launch is scheduled for no earlier than 2024. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:49 am

NVO

Novo Nordisk announced that its drug, semaglutide 2.4 mg, has reduced the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial. The trial achieved its primary objective, demonstrating a statistically significant reduction in MACE for people treated with semaglutide 2.4 mg compared to placebo. The drug also had a safe and well-tolerated profile.

Portfolio Pulse from Charles Gross

August 08, 2023 | 9:58 am

IGT

International Game Technology (IGT) has been granted U.S. Patent #11721160 for artificial intelligence (AI) implementations that modify user interface elements of a gaming device. This patent could potentially enhance the user experience and increase the competitiveness of IGT's gaming devices.

Portfolio Pulse from Charles Gross

August 08, 2023 | 9:34 am

AMZN

Amazon.com Inc. (NASDAQ:AMZN) is under scrutiny for allegedly hosting books authored by artificial intelligence under the name of a human author. The issue was brought to light by author Jane Friedman, who discovered books on Amazon's platform that were falsely attributed to her. Despite her complaint, Amazon has reportedly refused to remove the books due to lack of trademark registration for her name. The Author’s Guild intends to take up the matter with Amazon.

Portfolio Pulse from Ananya Gairola

August 08, 2023 | 9:24 am